Skip to main content
. 2022 May 19;107(9):e3866–e3876. doi: 10.1210/clinem/dgac318

Figure 2.

Figure 2.

The prevalence of abnormal mineral markers by rs4074995 (RGS14) genotype (28). The prevalence of hyperparathyroidism differs by rs4074995 (RGS14) genotype (chi-square P < .0001). The minor allele is A. The AA genotype had the lowest prevalence of hyperparathyroidism. The prevalence of hyperphosphatemia and fibroblast growth factor 23 (FGF23) excess were not significantly different between the genotypes: hyperphosphatemia (chi-square P = .08) and FGF23 excess (chi-square P = .8).